Literature DB >> 7357509

Neural control of colonic cell proliferation.

P J Tutton, D H Barkla.   

Abstract

The mitotic rate in rat colonic crypts and in dimethylhydrazine-induced colonic carcinomas was measured using a stathmokinetic technique. In sympathectomized animals cell proliferation was retarded in the crypts but not in the tumors, whereas in animals treated with Metaraminol, a drug which releases norepinephrine from nerve terminals, crypt cell but not tumor cell proliferation was accelerated. Blockade of alpha-adrenoceptors also inhibited crypt cell proliferation. However, stimulation of beta-adrenoceptors inhibited and blockade of beta-adrenoceptors accelerated tumor cell proliferation without influencing crypt cell proliferation. Injection of either serotonin or histamine stimulated tumor but not crypt cell proliferation and blockade or serotonin receptors or histamine H2-receptors inhibited tumor cell proliferation. It is postulated that cell proliferation in the colonic crypts, like that in the jejunal crypts, is under both endocrine and autonomic neural control whereas colonic tumor cell division is subject to endocrine regulation alone.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357509     DOI: 10.1002/1097-0142(19800315)45:5+<1172::aid-cncr2820451322>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature review.

Authors:  Cynthia M Nijenhuis; Peter G J ter Horst; Lolkje T W de Jong-van den Berg; Bob Wilffert
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

2.  Neuronal serotonin regulates growth of the intestinal mucosa in mice.

Authors:  Erica R Gross; Michael D Gershon; Kara G Margolis; Zoya V Gertsberg; Zhishan Li; Robert A Cowles
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

3.  Morphological and mucus secretion criteria for differential diagnosis of solitary ulcer syndrome and non-specific proctitis.

Authors:  M Ehsanullah; M I Filipe; B Gazzard
Journal:  J Clin Pathol       Date:  1982-01       Impact factor: 3.411

4.  Refeeding of fasting rats stimulates DNA synthesis in implanted colon carcinoma.

Authors:  J De Greve; J van der Elst; G Willems
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  Evaluation in rats of the dose-response relationship among colonic mucosal growth, colonic fermentation, and dietary fiber.

Authors:  L O Whiteley; J M Higgins; M P Purdon; G M Ridder; T A Bertram
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

6.  Endocrine differentiation in inflamed urinary bladder epithelium with metaplastic changes.

Authors:  Q A Hamid; J Rode; A M Flanagan; A P Dhillon; A E Bishop; M Stratton; D J Evans; J M Polak
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

7.  Isoprenaline protects intestinal stem cells from chemotherapy-induced damage.

Authors:  Huihong Zeng; Huan Li; Mengzhen Yue; Ying Fan; Jiaoqi Cheng; Xincheng Wu; Rui Xu; Wuping Yang; Manjun Li; Jiahui Tang; Hongping Chen; Bohai Kuang; Guangqin Fan; Qingxian Zhu; Lijian Shao
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

8.  Serotonin and the 5-HT(2B) receptor in the development of enteric neurons.

Authors:  E Fiorica-Howells; L Maroteaux; M D Gershon
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

9.  Intestinal epithelial stem/progenitor cells are controlled by mucosal afferent nerves.

Authors:  Ove Lundgren; Mats Jodal; Madeleine Jansson; Anders T Ryberg; Lennart Svensson
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

10.  Effects of cyclic-nucleotide derivatives on the growth of human colonic carcinoma xenografts and on cell production in the rat colonic crypt epithelium.

Authors:  P J Tutton; D H Barkla
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.